Yes, you are born with essentially all the eggs you will ever have. A female fetus peaks at roughly 6 to 7 million oocytes around 20 weeks of gestation, is born with about 1 to 2 million, and holds roughly 300,000 to 400,000 at puberty. That reserve never regenerates. It only declines, through a continuous process of follicular decay, until it reaches a few hundred to a thousand at menopause. The one genuine caveat is that very recent research has detected rare germline stem cell activity in adult ovaries, but no study has shown it produces viable eggs capable of fertilization, so the clinical answer remains unchanged: your egg supply is fixed before birth.
The Mechanism: Why the Count Only Goes Down
The oocyte reserve is set by mitosis that happens before birth. Primordial germ cells migrate to the fetal gonad, multiply rapidly, and then enter meiosis, arresting at the first meiotic division. From that point, no new oocytes are created. Each one sits inside a single layer of flattened granulosa cells, forming a primordial follicle.
From roughly mid-gestation onward, follicles leave this dormant pool continuously. Most never reach ovulation. They undergo atresia, a programmed death that removes roughly 99.9 percent of the starting reserve across a lifetime. Only about 400 to 500 follicles ever ovulate, and the rest are lost to decay regardless of pregnancy, breastfeeding, or hormonal contraception.
In plain terms: the ovary is not a factory that keeps producing eggs. It is a warehouse that opens its last crate decades after it was sealed.
The depletion rate is not linear. It is fast in fetal life, slows sharply after birth, accelerates again in the mid-30s, and becomes steepest in the final decade before menopause. That acceleration is driven partly by rising follicle-stimulating hormone as the remaining follicles become less responsive.
Quantified Context: The Full Follicle Timeline
The numbers below come from established histology and reproductive endocrinology literature. Fetal counts are estimates from stereological studies and vary by method, so treat the ranges as approximate rather than exact.
| Age or stage | Estimated follicle count | What is happening |
|---|---|---|
| 8 weeks gestation | ~600,000 | Primordial germ cells colonize the gonad; mitosis is active |
| 20 weeks gestation | 6–7 million | Peak oocyte number; meiosis has begun |
| Birth | 1–2 million | Atresia has already removed most of the peak |
| Puberty | 300,000–400,000 | Resting pool; monthly cohort recruitment begins |
| Age 30 | ~120,000 | Slow decline phase; fertility still relatively high |
| Age 37 | ~25,000 | Decline accelerates; antral follicle count falls |
| Age 45 | ~8,000 | Steep depletion; cycle irregularity common |
| Menopause (~51) | <1,000 | Ovulation ceases; follicle exhaustion |
The key ratio is the wastage rate. Of the 6 to 7 million oocytes at 20 weeks, fewer than 0.01 percent will ever ovulate. The other 99.99 percent are lost to atresia. That is why the reserve looks enormous at birth and yet still runs out.
For context, a woman ovulating roughly 450 times across a 35-year reproductive span uses about one egg per cycle. The other 999 to 1,000 recruited each month die before they ever mature.
Why Ovarian Reserve Varies So Widely Between Women
Two women of the same age can have reserves that differ by a factor of 5 to 10. This is not noise. It reflects real biological variation, and it explains why age alone is an imperfect predictor of fertility.
The strongest driver is the peak fetal count. Anything that reduces the number of oocytes established in utero, such as maternal smoking during pregnancy or certain chromosomal conditions, leaves a smaller starting pool. Turner syndrome (45,X) produces accelerated follicle loss and often premature ovarian insufficiency, sometimes before age 20.
Genetic factors matter too. FMR1 premutations, BRCA1 and BRCA2 variants, and a family history of early menopause all shift the depletion curve. Chemotherapy and pelvic radiation damage the reserve directly and can deplete it years ahead of schedule. Endometriosis, particularly ovarian endometriomas, also reduces follicle density.
Measuring reserve is a clinical exercise. Antral follicle count by transvaginal ultrasound and anti-Müllerian hormone (AMH) are the standard markers. AMH below roughly 1.1 ng/mL suggests diminished reserve, while below 0.5 ng/mL is low. Importantly, AMH predicts response to ovarian stimulation but does not reliably predict natural conception, because a low reserve still leaves viable eggs.
The Counterintuitive Detail: The Reserve Is Not a Fixed Clock
The intuitive model is a simple countdown. The reality is more nuanced, and it is where most explainers get it wrong.
Follicle loss is programmed, not random. A large fraction of oocytes are removed by apoptosis driven by the Bax gene and related pathways. When researchers knocked out Bax in mice, oocytes survived far longer and the reserve was preserved. That finding suggests atresia is an active regulated process, not passive decay. Human applications remain speculative, but it reframes the question from "how fast do eggs die" to "what controls the rate of death."
A second nuance is that follicle quality declines alongside quantity. Even with eggs remaining, chromosomal error rates in meiosis rise sharply after age 35, which is why miscarriage and aneuploidy rates climb independently of raw count. A woman at 40 with a decent reserve still faces egg quality limits that count alone does not capture.
The third nuance is the germline stem cell controversy. A 2004 paper by Johnson and colleagues in Nature reported mitotically active germ cells in mouse ovaries, challenging the fixed-reserve dogma. Subsequent work found rare stem-like cells in human ovarian tissue, but no study has demonstrated that they produce fertilizable oocytes in vivo, and a 2012 follow-up failed to confirm mitotic activity in adult human ovaries. The consensus position as of 2025 remains that human oocytes are not meaningfully replenished after birth.
Common Misconceptions About the Egg Supply
Several widespread beliefs are wrong, and correcting them matters for real decisions.
The first is that hormonal birth control "preserves" eggs. It does not. Combined oral contraceptives suppress ovulation, but follicles still leave the resting pool and undergo atresia. The reserve declines at essentially the same rate. The pill prevents pregnancy; it does not save eggs.
The second is that pregnancy or breastfeeding "uses up" eggs faster. Neither does. The depletion rate is set by age and biology, not by reproductive history. If anything, pregnancy temporarily suppresses follicular recruitment, but the net effect on long-term reserve is negligible.
The third is that AMH tells you when you will hit menopause. AMH correlates with reserve, but it is a weak predictor of exact timing for an individual woman. Two women with identical AMH can reach menopause five to 10 years apart.
The fourth is that every monthly cycle releases one egg from a batch that was "waiting." In reality, a cohort of 10 to 30 antral follicles is recruited each cycle, and only one becomes dominant. The rest die. The reserve is being spent every month whether or not pregnancy occurs.
What You Can Actually Do
There is no proven way to increase the number of eggs, but there are concrete actions that protect what exists and inform decisions.
- Stop smoking. Smoking accelerates follicle loss and shifts menopause earlier by roughly 1 to 2 years.
- Measure reserve if you are considering delaying pregnancy. AMH and antral follicle count are the standard tests.
- Discuss fertility preservation before gonadotoxic treatment. Egg freezing is most effective before age 35, and success rates fall steeply afterward.
- Treat conditions that damage the ovary. Endometriomas and severe endometriosis warrant prompt specialist input.
- Understand that age is the dominant variable. Reserve markers inform planning but do not override the age-related quality decline.
For anyone weighing egg freezing, the American Society for Reproductive Medicine's 2024 guidance notes that outcomes are best when oocytes are banked before age 35, with live birth rates per thawed egg declining markedly after 38. That is a planning threshold, not a guarantee.
Limitations and What Remains Uncertain
The headline claim is well established: the human egg supply is set before birth and declines continuously. But several details remain under active investigation.
Fetal counts vary by measurement technique, so the "6 to 7 million" figure is a consensus estimate rather than a precise census. Individual variation is large, and the exact mechanisms that time the depletion curve are not fully mapped. The germline stem cell question is unresolved at the margins, and rare reports of oocyte regeneration in humans have not been replicated in a way that changes clinical practice.
What is actionable is the timeline and its consequences. The reserve is largest before birth, smallest at menopause, and cannot be expanded. Planning fertility around that curve, rather than against it, is the most reliable strategy science currently supports.